Category: Pharmaceuticals
Pharmaceuticals market research reports by Euromonitor International
-
Pharmaceuticals in Mexico: ISIC 2423
PPI Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals: ISIC 2423 market at a national level. It provides the latest retail sales data, allowing you to identif ... Read More
-
Voice of the Consumer: Consumer Health 2024
This report highlights the results of Euromonitor International’s 2024 Voice of the Consumer: Health & Nutrition Survey, uncovering key trends in relation to the consumer health industry. Consumer trends explored include the battle between branded and generic OTCs, the rise of holistic health, and t ... Read More
-
Cannabis in South Africa
During 2024, the South African legal cannabis market continued to develop, following enactment of the Cannabis for Private Purposes Act, which codified the 2018 landmark judgement into law, by formally legalising personal cultivation and use of cannabis in private spaces. In turn, the change in the ... Read More
-
Cannabis in the US
The cannabis legalisation landscape is rapidly changing, with more states legalising it for medical and recreational use, driving market growth and consumer access. Significant federal developments may include a potential rescheduling of cannabis from Schedule I to Schedule III, which could attract ... Read More
-
Cannabis in Italy
Cannabis in Italy The year 2023 was characterised by a decline in medical cannabis consumption in Italy. This dynamic was due to several factors. The main reason lay in the fact that during 2023 some Italian doctors, who were major prescribers of medical cannabis, retired and there was no generation ... Read More
-
Cannabis in Thailand
Cannabis in Thailand The cannabis market has continued to experience significant turmoil largely due to inconsistent regulations from the Thai government that have dampened consumer demand and eroded producer confidence. While demand appeared to be in decline, a substantial number of cannabis shops ... Read More
-
Cannabis in Israel
Cannabis in Israel The first six months of 2024 were characterised by fluctuating inflation, with the rate rising again in July 2024 to 3.2%. At the end of Q1 2024, there was reported economic growth of just over 14%. However, in Q2 2024, economic growth had fallen to just 1.2% showing that the econ ... Read More
-
Paediatric Consumer Health in India
Paediatric Consumer Health in India Paediatric consumer health is set to experience steady mid-single-digit retail current value growth in India in 2024. A significant driver of this performance is the increasing concern amongst parents about ensuring their children receive the proper nutrition. Man ... Read More
-
Analgesics in India
Analgesics in India In 2024, analgesics in India is expected to experience high single-digit retail current value growth, driven by the increasing prevalence of lifestyle-related ailments. With more individuals working extended hours, often on digital devices, issues such as neck, back, and joint pa ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in India
Cough, Cold and Allergy (Hay Fever) Remedies in India In 2024, cough, cold and allergy (hay fever) remedies is set to see continued moderate retail current value growth in India. With sales of antihistamines/allergy remedies insignificant, cough and cold remedies are expected to account for the enti ... Read More
-
Herbal/Traditional Products in India
Herbal/Traditional Products in India Herbal/traditional products in India is projected to see robust retail current value growth in 2024, with sales and growth set to be driven primarily by herbal/traditional dietary supplements, as well as the overarching health and wellness trend. As consumers bec ... Read More
-
Vitamins in India
Vitamins in India Vitamins in India has been witnessing a notable shift in consumer preference, with single vitamins growing at a faster rate than multivitamins in retail current value terms, and this trend is set to be maintained in 2024. This change is primarily being driven by increasing awarenes ... Read More
-
Dermatologicals in India
Dermatologicals in India Dermatologicals in India is set to see mid-single-digit growth in retail current value terms in 2024, primarily driven by above-average growth for topical germicidals/antiseptics and topical antifungals. Trusted household brands such as Boroline, which has long been a staple ... Read More
-
NRT Smoking Cessation Aids in India
NRT Smoking Cessation Aids in India The health and wellness movement is playing a pivotal role in shaping consumer behaviour in India. As an increasing number of people prioritise their fitness, mental health, and disease prevention, smoking cessation has emerged as a natural step towards achieving ... Read More
-
Dietary Supplements in India
Dietary Supplements in India In 2024, dietary supplements in India is set to witness continued double-digit retail current value growth, with probiotic supplements and protein supplements expected to see the strongest increases. Probiotic supplements, which are known for their digestive health benef ... Read More
-
Digestive Remedies in India
Digestive Remedies in India In 2024, digestive remedies in India is set to experience moderate retail current value growth, with a particularly significant increase in sales of diarrhoeal remedies. According to data from the Ministry of Earth Sciences, India faced one of its harshest summers on reco ... Read More
-
Consumer Health in Latin America
Consumer Health in Latin America Growth remained positive in real value terms in the Latin American consumer health market in 2024, but was slower than a year earlier, given the steep decline seen in Argentina, still suffering from high inflation rates but also the austerity measures introduced by t ... Read More
-
Consumer Health in India
Consumer Health in India In 2024, consumer health in India is projected to grow at a strong pace in retail current value terms, with nearly a double-digit increase, driven by evolving consumer priorities and lifestyle changes. Key factors contributing to growth include rising disposable incomes, urb ... Read More
-
Product Innovation in Consumer Health
Product Innovation in Consumer Health This report utilises Euromonitor International’s new Passport Innovation portal to explore new launches and sub-brands in global consumer health. Three key innovation platforms are identified for global consumer health in 2024/2025, with examples of products fro ... Read More
-
Cannabis in Greece
Cannabis in Greece Greece has been historically a small cannabis market comprised of an overwhelming share of illicit value sales and a small percentage of CBD sales, whereas medical and adult-use cannabis products were not allowed. Despite scope being rather limited in 2024, the introduction of med ... Read More
-
Cannabis in Portugal
Cannabis in Portugal Prescriptions of medical cannabis remain low in Portugal. However, 2024 was marked by the introduction of five new cannabis-based medications, including one flower and four different oral solutions. Value sales of CBD and other non-intoxicating cannabinoids products became stagn ... Read More
-
Cannabis in the Czech Republic
Cannabis in the Czech Republic The cannabis market in the Czech Republic is poised for significant changes in 2025, driven by evolving legislation and shifting economic and demographic factors. Recent developments indicate that the initial ambitious plans to establish a legal commercial market for c ... Read More
-
Cannabis in the Netherlands
Cannabis in the Netherlands In 2024, the Dutch cannabis market continued to face economic challenges, although conditions showed some improvement compared to 2023. Inflation eased significantly but remained a concern, leading to cautious consumer spending habits. While price increases for CBD were m ... Read More
-
Cannabis in Switzerland
Cannabis in Switzerland Overall, demand for cannabis remained strong in Switzerland during 2024. Cannabis registered significant value sales growth throughout the year. The main reason for the strong growth was the excellent performance of adult-use cannabis. Adult-use cannabis recorded the fastest ... Read More
-
Cannabis in Japan
Cannabis in Japan Currently, the medical cannabis market is very limited in Japan, but the illegal cannabis market is growing along with the legal CBD market. In 1948, Japan’s Cannabis Control Act prohibited cannabis use, restricting its cultivation to purposes such as fibre, seeds and research, und ... Read More
Research Assistance
